These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 23172518)

  • 1. The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients.
    Baudino B; D'agata F; Caroppo P; Castellano G; Cauda S; Manfredi M; Geda E; Castelli L; Mortara P; Orsi L; Cauda F; Sacco K; Ardito RB; Pinessi L; Geminiani G; Torta R; Bisi G
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):559-68. PubMed ID: 23172518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate mechanisms for chemotherapy-induced cognitive changes.
    Ahles TA; Saykin AJ
    Nat Rev Cancer; 2007 Mar; 7(3):192-201. PubMed ID: 17318212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine.
    Zimmer P; Mierau A; Bloch W; Strüder HK; Hülsdünker T; Schenk A; Fiebig L; Baumann FT; Hahn M; Reinart N; Hallek M; Elter T
    Leuk Lymphoma; 2015 Feb; 56(2):347-52. PubMed ID: 24738942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment Cancer-Related Cognitive Impairment in Hodgkin Lymphoma Patients.
    Juríčková V; Fayette D; Jonáš J; Fajnerová I; Kozák T; Horáček J
    Curr Oncol; 2023 Oct; 30(10):9028-9038. PubMed ID: 37887552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of an individualized brain metabolic network in patients with advanced non-small cell lung cancer by the Kullback-Leibler divergence-based similarity method: A study based on 18F-fluorodeoxyglucose positron emission tomography.
    Yu J; Hua L; Cao X; Chen Q; Zeng X; Yuan Z; Wang Y
    Front Oncol; 2023; 13():1098748. PubMed ID: 36969017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A scoping review of cognitive assessment tools and domains for chemotherapy-induced cognitive impairments in cancer survivors.
    Saita K; Amano S; Kaneko F; Okamura H
    Front Hum Neurosci; 2023; 17():1063674. PubMed ID: 36891148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Regional Brain Glucose Metabolism in Diffuse Large B-Cell Lymphoma Patients Treated With Cyclophosphamide, Epirubicin, Vincristine, and Prednisone: An Fluorodeoxyglucose Positron Emission Tomography Study of 205 Cases.
    Hu Y; Zhang Q; Cui C; Zhang Y
    Front Neurosci; 2022; 16():914556. PubMed ID: 35784854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions.
    Onzi GR; D'Agustini N; Garcia SC; Guterres SS; Pohlmann PR; Rosa DD; Pohlmann AR
    Drug Saf; 2022 Jun; 45(6):601-621. PubMed ID: 35606623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional changes with global brain hypometabolism indicates a physiological triage phenomenon and can explain shared pathophysiological events in Alzheimer's & small vessel diseases and delirium.
    Gupta SK; Rutherford N; Dolja-Gore X; Watson T; Nair BR
    Am J Nucl Med Mol Imaging; 2021; 11(6):492-506. PubMed ID: 35003887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between anticancer drugs and mitochondrial functions.
    Sahu K; Langeh U; Singh C; Singh A
    Curr Res Pharmacol Drug Discov; 2021; 2():100047. PubMed ID: 34909674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.
    Dias-Carvalho A; Ferreira M; Ferreira R; Bastos ML; Sá SI; Capela JP; Carvalho F; Costa VM
    Arch Toxicol; 2022 Jan; 96(1):11-78. PubMed ID: 34725718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resting-state brain metabolic fingerprinting clusters (biomarkers) and predictive models for major depression in multiple myeloma patients.
    Wang X; Eichhorn J; Haq I; Baghal A
    PLoS One; 2021; 16(5):e0251026. PubMed ID: 33956824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurophysiologic and ophthalmic markers of chemotherapy-related cognitive impairment in patients diagnosed with hematologic cancer: A feasibility study.
    Anderson DE; Kedar S; Bhatt VR; Schmid K; Holstein SA; Rizzo M
    J Neurol Sci; 2020 Mar; 410():116644. PubMed ID: 31901718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurophysiological evidence of impaired attention and working memory in untreated hematologic cancer patients.
    Anderson DE; Bhatt VR; Schmid K; Holstein SA; Lunning M; Berger AM; Rizzo M
    Clin Neurophysiol; 2019 Aug; 130(8):1243-1252. PubMed ID: 31163369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment ("chemobrain"), a condition that significantly impairs the quality of life of many cancer survivors.
    Ren X; Boriero D; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1088-1097. PubMed ID: 30759363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological and immunohistochemical study of the protective effect of triptorelin on the neurocytes of the hippocampus and the cerebral cortex of male albino rats after short-term exposure to cyclophosphamide.
    Shaibah HS; Elsify AK; Medhat TM; Rezk HM; El-Sherbiny M
    J Microsc Ultrastruct; 2016; 4(3):123-132. PubMed ID: 30023218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis.
    Aide N; Salomon T; Lasnon C
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2233-2234. PubMed ID: 30008110
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive function and its relationship to other psychosocial factors in lymphoma survivors.
    Krolak D; Collins B; Weiss L; Harris C; Van der Jagt R
    Support Care Cancer; 2017 Mar; 25(3):905-913. PubMed ID: 27837322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early manifestation of mild cognitive impairment in B-cell non-Hodgkin's lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy.
    Khan MA; Garg K; Bhurani D; Agarwal NB
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1253-1265. PubMed ID: 27568029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.
    Williams AM; Zent CS; Janelsins MC
    Br J Haematol; 2016 Sep; 174(6):835-46. PubMed ID: 27391367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.